Abstract

Dihydroergotamine Mesylate 1-mg/mL Injection

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2013 - Volume 17, Number 6

Page(s): 503

Download in electronic PDF format for $75
  • Dihydroergotamine Mesylate 1-mg/mL Injection Page 1

Abstract

A formulation for preparing Dihydroergotamine Mesylate 1-mg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • dihydroergotamine mesylate
  • formulation
  • compounded sterile preparation
  • aseptic compounding technique
  • migraine headache
  • cranial vasodilator
  • vasodilation
  • ergot derivative

Related Categories

  • FORMULATIONS
  • PAIN MANAGEMENT
  • STERILE PREPARATIONS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2013
Pg. 503
Dihydroergotamine Mesylate 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2013
Pg. 498
Benztropine Mesylate 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 1998
Pg. 150
Dihydroergotamine Mesylate 1-mg Troches
Author(s): Allen Loyd V Jr
Jul/Aug 2012
Pg. 270-274
A Concise Discussion of Headache Types, Part 3: Migraine
Author(s): Williams LaVonn A, Allen Loyd V Jr
Mar/Apr 1998
Pg. 149
Dihydroergotamine Mesylate 2.5-mg/mL Nasal Spray
Author(s): Allen Loyd V Jr
Jul/Aug 2016
Pg. 318
Dolasetron Mesylate 20-mg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jan/Feb 2015
Pg. 69
Phentolamine Mesylate 5-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2015
Pg. 144
Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 387-398
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Author(s): Ashe Krystina, Baskett Dustin
Jan/Feb 2014
Pg. 6-12
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Mar/Apr 2004
Pg. 89-94
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists
Author(s): Rahe Hank
Nov/Dec 2021
Pg. 491-496
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 206-209
Basics of Compounding for Cold Sores or Fever Blisters
Author(s): Allen Loyd V Jr
Jan/Feb 2022
Pg. 41-49
Sterile Basics: Compounding Sterile Preparations with Cyclodextrins
Author(s): Allen Loyd V Jr
May/Jun 2019
Pg. 221-228
Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 447-452
Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators
Author(s): Mulder Kyle
May/Jun 2022
Pg. 219-228
Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Author(s): Allen Loyd V Jr